myNEWS-Line Account Login
Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Physical Therapists & PT Assistants
Physical Therapists & PT Assistants Physical Therapists & PT Assistants

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest





Physical Therapist Conferences &
Educational Opportunities


More Events

INTRAVENOUS SILDENAFIL SIGNIFICANTLY LOWERS PULMONARY VASCULAR RESISTANCE IN AN ANIMAL MODEL OF NEONATAL PULMONARY HYPERTENSION | NEWS-Line for Pediatric and Child Health Specialists

INTRAVENOUS SILDENAFIL SIGNIFICANTLY LOWERS PULMONARY VASCULAR RESISTANCE IN AN ANIMAL MODEL OF NEONATAL PULMONARY HYPERTENSION


Source:

In an animal model of persistent neonatal pulmonary hypertension, a serious killer of newborns, the vasodilator sildenafil completely reversed vascular resistance in six affected piglets within one hour after researchers began infusing the drug. The investigators were comparing the effects of intravenous sildenafil with inhaled nitric oxide (a standard treatment) in a piglet model of neonatal pulmonary hypertension caused by meconium aspiration. Meconium is the dark green material found in the intestine of the full-term infant. When the fetus inhales meconium, the substance can block the airways and irritate the lungs.

Severe meconium aspiration syndrome produces acute lung disease with rapid onset of persistent pulmonary hypertension. Current management of persistent pulmonary hypertension of the newborn includes therapies that are targeted at lowering vascular resistance, with inhaled nitric oxide as a key treatment. The six piglets that were instilled with human meconium, with a resulting increase in vascular resistance of 70 percent, had that level completely reversed within one hour of the start of sildenafil infusion.

This result was in contrast to those of the controls (no change) and the six piglets treated with nitric oxide (40 percent reduction in two hours). The researchers believe that sildenafil may play an important role in the future treatment of the illness.

The research appears in the second issue for April of the American Thoracic Society’s peer-reviewed American Journal of Respiratory and Critical Care Medicine.






Share This!









comments powered by Disqus

Physical Therapist Jobs



St. Scholastica

YappGuru

Physical Therapist

Accessible Space Inc
Nevada

SLPs, SLPAs, OTs & COTAs

Bright Futures Academy - Riverside
Inland Empire, California

Physical Therapist

Therapeutic Living Centers For The Blind
Reseda, California

Physical Therapist

Keystone Hospice
Philadelphia, Montgomery, Delaware and Bucks Counties, Pennsylvania

PT's, OT's, SLP's & Nurses too!

Bay Cliff Health Camp
Big Bay, Michigan

Full Time Physical Therapist

New Hampshire Neurospine Institute
New Hampshire

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.